Premium
Day 15 bone marrow minimal residual disease predicts response to blinatumomab in relapsed/refractory paediatric B‐ALL
Author(s) -
Brown Patrick,
Zugmaier Gerhard,
Gore Lia,
Tuglus Catherine A.,
Stackelberg Arend
Publication year - 2020
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/bjh.16306
Subject(s) - blinatumomab , medicine , minimal residual disease , refractory (planetary science) , bone marrow , bone marrow failure , immunology , oncology , antibody , stem cell , cd19 , haematopoiesis , biology , genetics , astrobiology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom